|
| Echocardiographic characteristics | Normal systolic LV-ejection fraction | Heart failure with reduced ejection fraction | p-value |
|
| Posterior wall thickness (mm, median, IQR) | 12 (10.5-13.5) | 12 (10.5-13.5) | 0.559 |
| Left ventricular enddiastolic volume (ml, median, IQR) | 43 (39.5-46.5) | 46 (40-52) | 0.001 |
| Left ventricular endsystolic volume (ml, median, IQR) | 25 (21-29) | 31 (26-36) | 0.001 |
| Left atrial diameter (mm, median, IQR) | 34 (29.5-38.5) | 42 (37.5-46.5) | <0.001 |
| Aortic sinus (mm, median, IQR) | 30 (26.5-33.5) | 30 (26.5-33.5) | 0.454 |
| Left ventricular ejection fraction (%,median, IQR) | 55 (55-55) | 44.5 (35.5-53.5) | <0.001 |
| Left ventricular hypertrophy | 138 (70.4%) | 49 (69.0%) | 0.826 |
| Left ventricular dilatation | 2 (1%) | 15 (21.7%) | <0.001 |
| Left atrial dilatation | 103 (58.5%) | 64 (91.4%) | <0.001 |
| Right ventricular dilatation | 12 (10.5% | 14 (40%) | <0.001 |
| Right atrial dilatation | 8 (19%) | 7 (77.8%) | 0.001 |
| Wall motion abnormalities | 5 (2.6%) | 53 (72.6%) | <0.001 |
| Congested inferior vena cava | 15 (8.8%) | 22 (34.4%) | <0.001 |
| Aortic insufficiency | 83 (42.1%) | 39 (61.9%) | 0.009 |
| Aortic valve stenosis | 25 (15.1%) | 10 (16.4%) | 0.805 |
| Mitral valve sclerosis | 30 (26.5%) | 10 (38.5%) | 0.237 |
| Mitral valve insufficiency | 181 (81.2%) | 78 (95.1%) | 0.003 |
| Pulmonary valve insufficiency | 47 (40.9%) | 14 (58.3%) | 0.174 |
| Tricuspid valve insufficiency | 164 (74.5%) | 69 (90.8%) | 0.003 |
| Thrombus in the Left atrial appendage | 4 (4.4%) | 2 (8.3%) | 0.440 |
| Endocarditis | 1 (2.8%) | 1 (10%) | 0.391 |
| Patent foramen ovale | 33 (18.9%) | 5 (11.4%) | 0.275 |
|
